Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
Merrimack Pharmaceuticals Dividend Announcement
• Merrimack Pharmaceuticals announced a semi annually dividend of $15.10 per ordinary share which will be made payable on . Ex dividend date: 2024-05-20
• Merrimack Pharmaceuticals annual dividend for 2024 was $15.10
• Merrimack Pharmaceuticals's trailing twelve-month (TTM) dividend yield is 99.7%
Merrimack Pharmaceuticals Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2024-05-20 | $15.10 | semi annually | |
| 2019-12-13 | $0.50 | semi annually | 2019-12-23 |
| 2019-09-06 | $1.50 | semi annually | |
| 2017-05-30 | $1.06 | semi annually |
Merrimack Pharmaceuticals Dividend per year
Merrimack Pharmaceuticals Dividend Yield
Merrimack Pharmaceuticals current trailing twelve-month (TTM) dividend yield is 99.7%. Interested in purchasing Merrimack Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:
Merrimack Pharmaceuticals Financial Ratios
P/E ratio-8.92
PEG ratio6.57
P/B ratio0.99
ROE-35.28%
Payout ratio0.00%
Current ratio10.78
Quick ratio10.78
Cash Ratio10.33
Merrimack Pharmaceuticals Dividend FAQ
Does Merrimack Pharmaceuticals stock pay dividends?
Merrimack Pharmaceuticals does not currently pay dividends to its shareholders.
Has Merrimack Pharmaceuticals ever paid a dividend?
No, Merrimack Pharmaceuticals has no a history of paying dividends to its shareholders. Merrimack Pharmaceuticals is not known for its dividend payments.
Why doesn't Merrimack Pharmaceuticals pay dividends?
There are several potential reasons why Merrimack Pharmaceuticals would choose not to pay dividends to their shareholders:
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Merrimack Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Merrimack Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Merrimack Pharmaceuticals a dividend aristocrat?
Merrimack Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Merrimack Pharmaceuticals a dividend king?
Merrimack Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Merrimack Pharmaceuticals a dividend stock?
No, Merrimack Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Merrimack Pharmaceuticals stocks?
To buy Merrimack Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.
Place an order: Use the brokerage's trading platform to place an order to buy Merrimack Pharmaceuticals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy Merrimack Pharmaceuticals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.